Drw Securities, LLC Catalyst Biosciences, Inc. Transaction History

Drw Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$9.35 - $12.44 $121,550 - $161,720	-13,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $118,429 - $375,440	13,000 New	13,000 $152,000
Q1 2018 May 14, 2018	SELL	$14.18 - $35.6 $170,160 - $427,200	-12,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.52 - $13.69 $54,239 - $164,280	12,000	12,000 $164,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.